Construction of an efficacy prediction model for active ulcerative colitis
Chinese Medical Informatics|更新时间:2023-05-09
|
Construction of an efficacy prediction model for active ulcerative colitis
Journal of Beijing University of Traditional Chinese MedicineVol. 46, Issue 4, Pages: 528-535(2023)
作者机构:
1.北京中医药大学循证医学中心 北京 100029
2.北京中医药大学第三附属医院
3.北京中医药大学东直门医院
4.北京中医药大学东方医院
5.中日友好医院
作者简介:
Prof. LIU Zhaolan, Ph.D., Doctoral Supervisor.Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, No.11, Beisanhuan Donglu Road, Chaoyang District, Beijing 100029. E-mail: lzl1019@163.com
基金信息:
National Natural Science Foundation of China(81904052);National Key Research and Development Program of China(2018YFC1705401-1)
WANG Xuehui, CHEN Yunru, ZHENG Youyou, et al. Construction of an efficacy prediction model for active ulcerative colitis[J]. Journal of beijing university of traditional chinese medicine, 2023, 46(4): 528-535.
DOI:
WANG Xuehui, CHEN Yunru, ZHENG Youyou, et al. Construction of an efficacy prediction model for active ulcerative colitis[J]. Journal of beijing university of traditional chinese medicine, 2023, 46(4): 528-535. DOI: 10.3969/j.issn.1006-2157.2023.04.012.
Construction of an efficacy prediction model for active ulcerative colitis
Based on the data of patients with ulcerative colitis treated with Five-Flavor Sophora Flavescens Radix Enteric-coated Capsules
we discuss the feasibility and methodology of constructing a prediction model of the efficacy of traditional Chinese medicine.
Methods
2
Based on phase Ⅲ clinical trial data of Five-Flavor Sophora Flavescens Radix Enteric-coated Capsules
a total of 274 patients with active ulcerative colitis with complete population data after 8 weeks of treatment in the experimental group (Five-Flavor Sophora Flavescens Radix Enteric-coated Capsules) were selected. R 4.1.0 was used for statistical analysis. First
all the variables to be screened were included to construct a multivariate Logistic regression model. Then
variables with
P
<
0.05 were screened for inclusion in the final model. The nomogram was plotted. The bootstrap method was used to resample 1 000 times for internal validation of the model
the C index was calculated
and the calibration chart was plotted to evaluate the discrimination and calibration of the model. The model was evaluated by the Hosmer-Lemeshow goodness of fit test and external validation. The overall evaluation of the model was performed by the above methods.
Results
2
The prognostic factors for complete remission of ulcerative colitis were younger age (15-65 years old) (
OR
=0.96
95%
CI
: 0.94-0.99
P
=0.002)
non-chronic persistent (compared with primary type) (
OR
=0.36
95%
CI
: 0.18-0.74
P
=0.005)
no microscopic bleeding (
OR
=0.42
95%
CI
: 0.22-0.82
P
=0.011)
and decreased erythrocyte sedimentation rate (
OR
=0.97
95%
CI
: 0.95-0.99
P
=0.006). We used the above variables to construct the final model and drew a nomogram. The corrected C index was 0.735 (95%
CI
: 0.672-0.797)
indicating that the model’s discrimination was acceptable. The calibration diagram shows that the calibration curve and the standard line roughly fit
indicating the calibration model is acceptable. The Hosmer-Lemeshow goodness of fit test (χ
2
=7.07
P
=0.53) showed that the model was well fitted. We conducted an external test of the prediction model. The C index and confidence interval were 0.54(95%
CI
: 0.44-0.65).
Conclusion
2
It is feasible to construct a prediction model by using data from randomized controlled trials. A prediction model based on the study data may provide an effective evaluation tool for clinical monitoring and targeted therapy after large sample validation.
关键词
Keywords
references
MOONS KG , ROYSTON P , VERGOUWE Y , et al . Prognosis and prognostic research: what, why, and how? [J/OL]. BMJ , 2009 , 23 ( 338 ): b375 [ 2022-09-24 ]. https://www.bmj.com/content/338/bmj.b375.long https://www.bmj.com/content/338/bmj.b375.long .
HAYBITTLE JL , BLAMEY RW , ELSTON CW , et al . A prognostic index in primary breast cancer [J/OL]. Br J Cancer , 1982 , 45 ( 3 ): 361 - 366 [ 2022-09-24 ]. https://sci-hub.se/10.1038/bjc.1982.62 https://sci-hub.se/10.1038/bjc.1982.62 .
PAJOUHESHNIA R , GROENWOLD RHH , PEELEN LM , et al . When and how to use data from randomised trials to develop or validate prognostic models [J/OL]. BMJ , 2019 , 29 ( 365 ): l2154 [ 2022-09-24 ]. https://sci-hub.se/10.1136/bmj.l2154 https://sci-hub.se/10.1136/bmj.l2154 .
TONG ZQ , YANG B , CHEN BY , et al . A multi-center, randomized, single-blind, controlled clinical study on the efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis [J]. Chin J Integr Med , 2010 , 16 ( 6 ): 486 - 492 .
STEYERBERG EW , VERGOUWE Y . Towards better clinical prediction models: seven steps for development and an ABCD for validation [J]. Eur Heart J , 2014 , 35 ( 29 ): 1925 - 1931 .
DORRESTEIJN JA , VISSEREN FL , WASSINK AM , et al . Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score [J]. Heart , 2013 , 99 ( 12 ): 866 - 872 .